Hepatobiliary Pancreat Dis Int

	129	Kodali S, Connor AA, Thabet S, Brombosz EW, Ghobrial RM

		Liver transplantation as an alternative for the treatment of intrahepatic cholangiocarcinoma: Past, present, and future directions
		2024 Vol. 23 (2): 129-138 [Abstract] ( 16 ) [HTML 0 KB][PDF 0 KB] (46)

	123	Bhangui P

		Liver transplantation and resection in patients with hepatocellular cancer and portal vein tumor thrombosis: Feasible and effective?
		2024 Vol. 23 (2): 123-128 [Abstract] ( 10 ) [HTML 0 KB][PDF 0 KB] (31)

	117	Yang X, Lu L, Zhu WW, Tao YF, Shen CH, Chen JH, Wang ZX, Qin LX

		Ex vivo liver resection and auto-transplantation as an alternative for the treatment of liver malignancies: Progress and challenges
		2024 Vol. 23 (2): 117-122 [Abstract] ( 13 ) [HTML 0 KB][PDF 0 KB] (26)

	111	Lerut J

		Liver transplantation and liver resection as alternative treatments for primary hepatobiliary and secondary liver tumors: Competitors or allies?
		2024 Vol. 23 (2): 111-116 [Abstract] ( 10 ) [HTML 0 KB][PDF 0 KB] (43)

	71	Fugazza A, Colombo M, Kahaleh M, Muthusamy VR, Benjamin B, Laleman W, Barbera C, Fabbri C, Nieto J, Al-Lehibi A,

		The outcomes and safety of patients undergoing endoscopic retrograde cholangiopancreatography combining a single-use cholangioscope and a single-use duodenoscope: A multicenter retrospective international study
		2024 Vol. 23 (1): 71-76 [Abstract] ( 45 ) [HTML 0 KB][PDF 0 KB] (27)

	25	Bao HL, Chen CZ, Ren CZ, Sun KY, Liu H, Song SH, Fu ZR

		Polydatin ameliorates hepatic ischemia-reperfusion injury by modulating macrophage polarization
		2024 Vol. 23 (1): 25-34 [Abstract] ( 52 ) [HTML 0 KB][PDF 0 KB] (55)

	14	de la Pinta C

		Stereotactic body radiotherapy in pancreatic adenocarcinoma
		2024 Vol. 23 (1): 14-19 [Abstract] ( 35 ) [HTML 0 KB][PDF 0 KB] (25)

	1	Huang HK, Li YM, Xu CF

		Pre-MASLD: Should it be defined separately?
		2024 Vol. 23 (1): 1-3 [Abstract] ( 21 ) [HTML 0 KB][PDF 0 KB] (79)

	632	Tong T, Tian L, Deng MZ, Chen XJ, Fu T, Ma KJ, Xu JH, Wang XY

		The efficacy and safety of endoscopic ultrasound-guided fine-needle biopsy in gallbladder masses
		2023 Vol. 22 (6): 632-638 [Abstract] ( 21 ) [HTML 0 KB][PDF 0 KB] (28)

	594	Wang DD, Zhang JF, Zhang LH, Niu M, Jiang HJ, Jia FC, Feng ST

		Clinical-radiomics predictors to identify the suitability of transarterial chemoembolization treatment in intermediate-stage hepatocellular carcinoma: A multicenter study
		2023 Vol. 22 (6): 594-604 [Abstract] ( 24 ) [HTML 0 KB][PDF 0 KB] (114)

	584	Wang Y, Zou CL, Zhang J, Qiu LX, Huang YF, Zhao XY, Zou ZS, Jia JD

		Development and validation of a novel model to predict liver-related mortality in patients with idiosyncratic drug-induced liver injury
		2023 Vol. 22 (6): 584-593 [Abstract] ( 20 ) [HTML 0 KB][PDF 0 KB] (31)

	577	Shen T, Zheng SH, Chen J, Zhou ZS, Yang MF, Liu XY, Chen JL, Zheng SS, Xu X

		Older liver grafts from donation after circulatory death are associated with impaired survival and higher incidence of biliary non-anastomotic structure
		2023 Vol. 22 (6): 577-583 [Abstract] ( 15 ) [HTML 0 KB][PDF 0 KB] (22)

	554	Bekheit M, Grundy L, Salih AKA, Bucur P, Vibert E, Ghazanfar M

		Post-hepatectomy liver failure: A timeline centered review
		2023 Vol. 22 (6): 554-569 [Abstract] ( 20 ) [HTML 0 KB][PDF 0 KB] (20)

	474	Hartmann P, Lang S, Schierwagen R, Klein S, Praktiknjo M, Trebicka J, Schnabl B

		Fecal cytolysin does not predict disease severity in acutely decompensated cirrhosis and acute-on-chronic liver failure
		2023 Vol. 22 (5): 474-481 [Abstract] ( 65 ) [HTML 0 KB][PDF 0 KB] (32)

	452	Jiang L, Xu J, Cheng SY, Wang Y, Cai W

		The gut microbiome and intestinal failure-associated liver disease
		2023 Vol. 22 (5): 452-457 [Abstract] ( 42 ) [HTML 0 KB][PDF 0 KB] (30)

	444	Wu MY, Fan JG

		Gut microbiome and nonalcoholic fatty liver disease
		2023 Vol. 22 (5): 444-451 [Abstract] ( 33 ) [HTML 0 KB][PDF 0 KB] (28)

	441	Jiang L, Fan JG

		The role of the gut microbiome in chronic liver diseases: Present insights and future outlook
		2023 Vol. 22 (5): 441-443 [Abstract] ( 48 ) [HTML 0 KB][PDF 0 KB] (30)

	358	Guo ZY, Hong Y, Tu B, Cheng Y, Wang XM

		Laparoscopic liver resection for hepatocellular carcinoma complicated with significant portal hypertension: A propensity score-matched survival analysis
		2023 Vol. 22 (4): 358-365 [Abstract] ( 84 ) [HTML 0 KB][PDF 0 KB] (47)

	346	Jiang C, Cai YQ, Yang JJ, Ma CY, Chen JX, Huang L, Xiang Z, Wu J

		Radiomics in the diagnosis and treatment of hepatocellular carcinoma
		2023 Vol. 22 (4): 346-351 [Abstract] ( 68 ) [HTML 0 KB][PDF 0 KB] (134)

	333	Shree Harini K, Ezhilarasan D

		Wnt/beta-catenin signaling and its modulators in nonalcoholic fatty liver diseases
		2023 Vol. 22 (4): 333-345 [Abstract] ( 72 ) [HTML 0 KB][PDF 0 KB] (135)

											
											Page 1 of 20
											389 records

Copyright © Official Publication of First Affiliated Hospital
Official Publication of First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
浙ICP备05050873号-1